1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Medicine
1.2.3 Surgery
1.2.4 Other
1.3 Market by Application
1.3.1 Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Androgen Deprivation Therapy (ADT) Market Perspective (2017-2028)
2.2 Androgen Deprivation Therapy (ADT) Growth Trends by Region
2.2.1 Androgen Deprivation Therapy (ADT) Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Androgen Deprivation Therapy (ADT) Historic Market Size by Region (2017-2022)
2.2.3 Androgen Deprivation Therapy (ADT) Forecasted Market Size by Region (2023-2028)
2.3 Androgen Deprivation Therapy (ADT) Market Dynamics
2.3.1 Androgen Deprivation Therapy (ADT) Industry Trends
2.3.2 Androgen Deprivation Therapy (ADT) Market Drivers
2.3.3 Androgen Deprivation Therapy (ADT) Market Challenges
2.3.4 Androgen Deprivation Therapy (ADT) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Androgen Deprivation Therapy (ADT) Players by Revenue
3.1.1 Global Top Androgen Deprivation Therapy (ADT) Players by Revenue (2017-2022)
3.1.2 Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Players (2017-2022)
3.2 Global Androgen Deprivation Therapy (ADT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Androgen Deprivation Therapy (ADT) Revenue
3.4 Global Androgen Deprivation Therapy (ADT) Market Concentration Ratio
3.4.1 Global Androgen Deprivation Therapy (ADT) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Androgen Deprivation Therapy (ADT) Revenue in 2021
3.5 Androgen Deprivation Therapy (ADT) Key Players Head office and Area Served
3.6 Key Players Androgen Deprivation Therapy (ADT) Product Solution and Service
3.7 Date of Enter into Androgen Deprivation Therapy (ADT) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Androgen Deprivation Therapy (ADT) Breakdown Data by Type
4.1 Global Androgen Deprivation Therapy (ADT) Historic Market Size by Type (2017-2022)
4.2 Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Type (2023-2028)
5 Androgen Deprivation Therapy (ADT) Breakdown Data by Application
5.1 Global Androgen Deprivation Therapy (ADT) Historic Market Size by Application (2017-2022)
5.2 Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Androgen Deprivation Therapy (ADT) Market Size (2017-2028)
6.2 North America Androgen Deprivation Therapy (ADT) Market Size by Type
6.2.1 North America Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022)
6.2.2 North America Androgen Deprivation Therapy (ADT) Market Size by Type (2023-2028)
6.2.3 North America Androgen Deprivation Therapy (ADT) Market Share by Type (2017-2028)
6.3 North America Androgen Deprivation Therapy (ADT) Market Size by Application
6.3.1 North America Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022)
6.3.2 North America Androgen Deprivation Therapy (ADT) Market Size by Application (2023-2028)
6.3.3 North America Androgen Deprivation Therapy (ADT) Market Share by Application (2017-2028)
6.4 North America Androgen Deprivation Therapy (ADT) Market Size by Country
6.4.1 North America Androgen Deprivation Therapy (ADT) Market Size by Country (2017-2022)
6.4.2 North America Androgen Deprivation Therapy (ADT) Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Androgen Deprivation Therapy (ADT) Market Size (2017-2028)
7.2 Europe Androgen Deprivation Therapy (ADT) Market Size by Type
7.2.1 Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022)
7.2.2 Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2023-2028)
7.2.3 Europe Androgen Deprivation Therapy (ADT) Market Share by Type (2017-2028)
7.3 Europe Androgen Deprivation Therapy (ADT) Market Size by Application
7.3.1 Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022)
7.3.2 Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2023-2028)
7.3.3 Europe Androgen Deprivation Therapy (ADT) Market Share by Application (2017-2028)
7.4 Europe Androgen Deprivation Therapy (ADT) Market Size by Country
7.4.1 Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2017-2022)
7.4.2 Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size (2017-2028)
8.2 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Type
8.2.1 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Share by Type (2017-2028)
8.3 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Application
8.3.1 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Share by Application (2017-2028)
8.4 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region
8.4.1 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Androgen Deprivation Therapy (ADT) Market Size (2017-2028)
9.2 Latin America Androgen Deprivation Therapy (ADT) Market Size by Type
9.2.1 Latin America Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022)
9.2.2 Latin America Androgen Deprivation Therapy (ADT) Market Size by Type (2023-2028)
9.2.3 Latin America Androgen Deprivation Therapy (ADT) Market Share by Type (2017-2028)
9.3 Latin America Androgen Deprivation Therapy (ADT) Market Size by Application
9.3.1 Latin America Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022)
9.3.2 Latin America Androgen Deprivation Therapy (ADT) Market Size by Application (2023-2028)
9.3.3 Latin America Androgen Deprivation Therapy (ADT) Market Share by Application (2017-2028)
9.4 Latin America Androgen Deprivation Therapy (ADT) Market Size by Country
9.4.1 Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2017-2022)
9.4.2 Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size (2017-2028)
10.2 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Type
10.2.1 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Share by Type (2017-2028)
10.3 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Application
10.3.1 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Share by Application (2017-2028)
10.4 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country
10.4.1 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Androgen Deprivation Therapy (ADT) Introduction
11.1.4 Pfizer Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022)
11.1.5 Pfizer Recent Developments
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Details
11.2.2 Astellas Pharma Business Overview
11.2.3 Astellas Pharma Androgen Deprivation Therapy (ADT) Introduction
11.2.4 Astellas Pharma Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022)
11.2.5 Astellas Pharma Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Androgen Deprivation Therapy (ADT) Introduction
11.3.4 Johnson & Johnson Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022)
11.3.5 Johnson & Johnson Recent Developments
11.4 Novartis International
11.4.1 Novartis International Company Details
11.4.2 Novartis International Business Overview
11.4.3 Novartis International Androgen Deprivation Therapy (ADT) Introduction
11.4.4 Novartis International Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022)
11.4.5 Novartis International Recent Developments
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Androgen Deprivation Therapy (ADT) Introduction
11.5.4 Merck Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022)
11.5.5 Merck Recent Developments
11.6 Veru
11.6.1 Veru Company Details
11.6.2 Veru Business Overview
11.6.3 Veru Androgen Deprivation Therapy (ADT) Introduction
11.6.4 Veru Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022)
11.6.5 Veru Recent Developments
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Androgen Deprivation Therapy (ADT) Introduction
11.7.4 Sanofi Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022)
11.7.5 Sanofi Recent Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Androgen Deprivation Therapy (ADT) Introduction
11.8.4 GlaxoSmithKline Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022)
11.8.5 GlaxoSmithKline Recent Developments
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Androgen Deprivation Therapy (ADT) Introduction
11.9.4 Bayer Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022)
11.9.5 Bayer Recent Developments
11.10 Orion
11.10.1 Orion Company Details
11.10.2 Orion Business Overview
11.10.3 Orion Androgen Deprivation Therapy (ADT) Introduction
11.10.4 Orion Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022)
11.10.5 Orion Recent Developments
11.11 AstraZeneca
11.11.1 AstraZeneca Company Details
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Androgen Deprivation Therapy (ADT) Introduction
11.11.4 AstraZeneca Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022)
11.11.5 AstraZeneca Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Medicine
Table 3. Key Players of Surgery
Table 4. Key Players of Other
Table 5. Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Androgen Deprivation Therapy (ADT) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Androgen Deprivation Therapy (ADT) Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Androgen Deprivation Therapy (ADT) Market Share by Region (2017-2022)
Table 9. Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Androgen Deprivation Therapy (ADT) Market Share by Region (2023-2028)
Table 11. Androgen Deprivation Therapy (ADT) Market Trends
Table 12. Androgen Deprivation Therapy (ADT) Market Drivers
Table 13. Androgen Deprivation Therapy (ADT) Market Challenges
Table 14. Androgen Deprivation Therapy (ADT) Market Restraints
Table 15. Global Androgen Deprivation Therapy (ADT) Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Androgen Deprivation Therapy (ADT) Revenue Share by Players (2017-2022)
Table 17. Global Top Androgen Deprivation Therapy (ADT) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Androgen Deprivation Therapy (ADT) as of 2021)
Table 18. Ranking of Global Top Androgen Deprivation Therapy (ADT) Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Androgen Deprivation Therapy (ADT) Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Androgen Deprivation Therapy (ADT) Product Solution and Service
Table 22. Date of Enter into Androgen Deprivation Therapy (ADT) Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Type (2017-2022)
Table 26. Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Type (2023-2028)
Table 28. Global Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Androgen Deprivation Therapy (ADT) Revenue Share by Application (2017-2022)
Table 30. Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Androgen Deprivation Therapy (ADT) Revenue Share by Application (2023-2028)
Table 32. North America Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Androgen Deprivation Therapy (ADT) Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Androgen Deprivation Therapy (ADT) Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Androgen Deprivation Therapy (ADT) Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Androgen Deprivation Therapy (ADT) Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Androgen Deprivation Therapy (ADT) Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Androgen Deprivation Therapy (ADT) Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Androgen Deprivation Therapy (ADT) Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Androgen Deprivation Therapy (ADT) Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Androgen Deprivation Therapy (ADT) Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Androgen Deprivation Therapy (ADT) Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Androgen Deprivation Therapy (ADT) Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Androgen Deprivation Therapy (ADT) Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2023-2028) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Androgen Deprivation Therapy (ADT) Product
Table 65. Pfizer Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022) & (US$ Million)
Table 66. Pfizer Recent Developments
Table 67. Astellas Pharma Company Details
Table 68. Astellas Pharma Business Overview
Table 69. Astellas Pharma Androgen Deprivation Therapy (ADT) Product
Table 70. Astellas Pharma Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022) & (US$ Million)
Table 71. Astellas Pharma Recent Developments
Table 72. Johnson & Johnson Company Details
Table 73. Johnson & Johnson Business Overview
Table 74. Johnson & Johnson Androgen Deprivation Therapy (ADT) Product
Table 75. Johnson & Johnson Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022) & (US$ Million)
Table 76. Johnson & Johnson Recent Developments
Table 77. Novartis International Company Details
Table 78. Novartis International Business Overview
Table 79. Novartis International Androgen Deprivation Therapy (ADT) Product
Table 80. Novartis International Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022) & (US$ Million)
Table 81. Novartis International Recent Developments
Table 82. Merck Company Details
Table 83. Merck Business Overview
Table 84. Merck Androgen Deprivation Therapy (ADT) Product
Table 85. Merck Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022) & (US$ Million)
Table 86. Merck Recent Developments
Table 87. Veru Company Details
Table 88. Veru Business Overview
Table 89. Veru Androgen Deprivation Therapy (ADT) Product
Table 90. Veru Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022) & (US$ Million)
Table 91. Veru Recent Developments
Table 92. Sanofi Company Details
Table 93. Sanofi Business Overview
Table 94. Sanofi Androgen Deprivation Therapy (ADT) Product
Table 95. Sanofi Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022) & (US$ Million)
Table 96. Sanofi Recent Developments
Table 97. GlaxoSmithKline Company Details
Table 98. GlaxoSmithKline Business Overview
Table 99. GlaxoSmithKline Androgen Deprivation Therapy (ADT) Product
Table 100. GlaxoSmithKline Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022) & (US$ Million)
Table 101. GlaxoSmithKline Recent Developments
Table 102. Bayer Company Details
Table 103. Bayer Business Overview
Table 104. Bayer Androgen Deprivation Therapy (ADT) Product
Table 105. Bayer Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022) & (US$ Million)
Table 106. Bayer Recent Developments
Table 107. Orion Company Details
Table 108. Orion Business Overview
Table 109. Orion Androgen Deprivation Therapy (ADT) Product
Table 110. Orion Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022) & (US$ Million)
Table 111. Orion Recent Developments
Table 112. AstraZeneca Company Details
Table 113. AstraZeneca Business Overview
Table 114. AstraZeneca Androgen Deprivation Therapy (ADT) Product
Table 115. AstraZeneca Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022) & (US$ Million)
Table 116. AstraZeneca Recent Developments
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Androgen Deprivation Therapy (ADT) Market Share by Type: 2021 VS 2028
Figure 2. Medicine Features
Figure 3. Surgery Features
Figure 4. Other Features
Figure 5. Global Androgen Deprivation Therapy (ADT) Market Share by Application: 2021 VS 2028
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Other Case Studies
Figure 9. Androgen Deprivation Therapy (ADT) Report Years Considered
Figure 10. Global Androgen Deprivation Therapy (ADT) Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Androgen Deprivation Therapy (ADT) Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Androgen Deprivation Therapy (ADT) Market Share by Region: 2021 VS 2028
Figure 13. Global Androgen Deprivation Therapy (ADT) Market Share by Players in 2021
Figure 14. Global Top Androgen Deprivation Therapy (ADT) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Androgen Deprivation Therapy (ADT) as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Androgen Deprivation Therapy (ADT) Revenue in 2021
Figure 16. North America Androgen Deprivation Therapy (ADT) Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Androgen Deprivation Therapy (ADT) Market Size Market Share by Type (2017-2028)
Figure 18. North America Androgen Deprivation Therapy (ADT) Market Size Market Share by Application (2017-2028)
Figure 19. North America Androgen Deprivation Therapy (ADT) Market Size Share by Country (2017-2028)
Figure 20. United States Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Androgen Deprivation Therapy (ADT) Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Androgen Deprivation Therapy (ADT) Market Size Market Share by Type (2017-2028)
Figure 24. Europe Androgen Deprivation Therapy (ADT) Market Size Market Share by Application (2017-2028)
Figure 25. Europe Androgen Deprivation Therapy (ADT) Market Size Share by Country (2017-2028)
Figure 26. Germany Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Androgen Deprivation Therapy (ADT) Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Androgen Deprivation Therapy (ADT) Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Androgen Deprivation Therapy (ADT) Market Size Share by Region (2017-2028)
Figure 36. China Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 42. Latin America Androgen Deprivation Therapy (ADT) Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Androgen Deprivation Therapy (ADT) Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Androgen Deprivation Therapy (ADT) Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Androgen Deprivation Therapy (ADT) Market Size Share by Country (2017-2028)
Figure 46. Mexico Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Androgen Deprivation Therapy (ADT) Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Androgen Deprivation Therapy (ADT) Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Androgen Deprivation Therapy (ADT) Market Size Share by Country (2017-2028)
Figure 52. Turkey Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Pfizer Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2017-2022)
Figure 56. Astellas Pharma Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2017-2022)
Figure 57. Johnson & Johnson Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2017-2022)
Figure 58. Novartis International Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2017-2022)
Figure 59. Merck Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2017-2022)
Figure 60. Veru Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2017-2022)
Figure 61. Sanofi Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2017-2022)
Figure 62. GlaxoSmithKline Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2017-2022)
Figure 63. Bayer Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2017-2022)
Figure 64. Orion Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2017-2022)
Figure 65. AstraZeneca Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
